Table of contents
Volume 85, Issue 8
Published online 16 October 2001 (1085-1231)
Editorial
Measuring changes in human tumour vasculature in response to therapy using functional imaging techniques FREE
H Anderson, P Price, M Blomley, M O Leach and P Workman
Br J Cancer 85: 1085-1093; doi:10.1054/bjoc.2001.2077
Review
Heparan sulfate proteoglycans and cancer FREE
F H Blackhall, C L R Merry, E J Davies and G C Jayson
Br J Cancer 85: 1094-1098; doi:10.1054/bjoc.2001.2054
Regular Articles
Effective cross-over to granisetron after failure to ondansetron, a randomized double blind study in patients failing ondansetron plus dexamethasone during the first 24 hours following highly emetogenic chemotherapy FREE
R de Wit, A C de Boer, G H M vd Linden, G Stoter, A Sparreboom and J Verweij
Br J Cancer 85: 1099-1101; doi:10.1054/bjoc.2001.2045
Differential p53 protein expression in breast cancer fine needle aspirates: the potential for in vivo monitoring FREE
H M-L Ball, T R Hupp, D Ziyaie, C A Purdie, N M Kernohan and A M Thompson
Br J Cancer 85: 1102-1105; doi:10.1054/bjoc.2001.2064
Relationship between tumour shrinkage and reduction in Ki67 expression after primary chemotherapy in human breast cancer FREE
A Bottini, A Berruti, A Bersiga, M P Brizzi, P Bruzzi, S Aguggini, A Brunelli, G Bolsi, G Allevi, D Generali, E Betri, G Bertoli, P Alquati and L Dogliotti
Br J Cancer 85: 1106-1112; doi:10.1054/bjoc.2001.2048
Failure-specific prognostic factors after continuous hyperfractionated accelerated radiotherapy (CHART) or conventional radiotherapy in locally advanced non-small-cell lung cancer: A competing risks analysis FREE
Ö U Ataman, S M Bentzen, M I Saunders and S Dische
Br J Cancer 85: 1113-1118; doi:10.1054/bjoc.2001.2049
Sequential detection of alphafetoprotein-bearing cells in blood stem cell fraction of germ cell tumour patients FREE
T Kasahara, N Hara, V Bilim, Y Tomita, K Saito, K Obara and K Takahashi
Br J Cancer 85: 1119-1123; doi:10.1054/bjoc.2001.2050
Dose and schedule-finding study of oral topotecan and weekly cisplatin in patients with recurrent ovarian cancer FREE
H Gelderblom, A Sparreboom, M J A de Jonge, W J Loos, E Wilms, M A Mantel, B Hennis, I Camlett, J Verweij and M E L van der Burg
Br J Cancer 85: 1124-1129; doi:10.1054/bjoc.2001.2014
IL-2 in combination with IFN-
and 5-FU versus tamoxifen in metastatic renal cell carcinoma: long-term results of a controlled randomized clinical trial FREE
J Atzpodien, H Kirchner, H J Illiger, B Metzner, D Ukena, H Schott, P J Funke, M Gramatzki, S von Jürgenson, T Wandert, T Patzelt, M Reitz and D. G. C. I. N. (German Cooperative Renal Carcinoma Chemo-Immunotherapy Trials Group)
Br J Cancer 85: 1130-1136; doi:10.1054/bjoc.2001.2076
A novel strategy for NQO1 (NAD(P)H:quinone oxidoreductase, EC 1.6.99.2) mediated therapy of bladder cancer based on the pharmacological properties of EO9 FREE
G A Choudry, P A Hamilton Stewart, J A Double, M R L Krul, B Naylor, G M Flannigan, T K Shah, J E Brown and R M Phillips
Br J Cancer 85: 1137-1146; doi:10.1054/bjoc.2001.2056
Expression of hMLH1 is inactivated in the gastric adenomas with enhanced microsatellite instability FREE
M J Baek, H Kang, S E Kim, J H Park, J S Lee, Y-K Paik and H Kim
Br J Cancer 85: 1147-1152; doi:10.1054/bjoc.2001.2051
The significance of p53 codon 72 polymorphism for the development of cervical adenocarcinomas FREE
S Andersson, E Rylander, A Strand, J Sällström and E Wilander
Br J Cancer 85: 1153-1156; doi:10.1054/bjoc.2001.2085
Chromosomal radiosensitivity in G2-phase lymphocytes identifies breast cancer patients with distinctive tumour characteristics FREE
A C Riches, P E Bryant, C M Steel, A Gleig, A J Robertson, P E Preece and A M Thompson
Br J Cancer 85: 1157-1161; doi:10.1054/bjoc.2001.2086
Identification and characterization of a novel human hepatocellular carcinoma-associated gene FREE
Z-X Wang, H-Y Wang and M-C Wu
Br J Cancer 85: 1162-1167; doi:10.1054/bjoc.2001.2059
Loss of expression of HDAC-recruiting methyl-CpG-binding domain proteins in human cancer FREE
C Müller-Tidow, K Kügler, S Diederichs, S Klümpen, M Möller, U Vogt, R Metzger, P M Schneider, W E Berdel and H Serve
Br J Cancer 85: 1168-1174; doi:10.1054/bjoc.2001.2041
Cross-talk between signalling pathways and the multidrug resistant protein MDR-1 FREE
S Ding, M Chamberlain, A McLaren, L-b Goh, I Duncan and C R Wolf
Br J Cancer 85: 1175-1184; doi:10.1054/bjoc.2001.2044
Down-regulation of Fas-L in glioma cells by ribozyme reduces cell apoptosis, tumour-infiltrating cells, and liver damage but accelerates tumour formation in nude mice FREE
C-C Chio, Y-S Wang, Y-L Chen, S-J Lin and B-C Yang
Br J Cancer 85: 1185-1192; doi:10.1054/bjoc.2001.2055
Cathepsin S in tumours, regional lymph nodes and sera of patients with lung cancer: relation to prognosis FREE
J Kos, A Sekirnik, G Kopitar, N Cimerman, K Kayser, A Stremmer, W Fiehn and B Werle
Br J Cancer 85: 1193-1200; doi:10.1054/bjoc.2001.2057
Frequent somatic loss of BRCA1 in breast tumours from BRCA2 germ-line mutation carriers and vice versa FREE
S Staff, J J Isola, O Johannsson, Å Borg and M M Tanner
Br J Cancer 85: 1201-1205; doi:10.1054/bjoc.2001.2062
Short Communication
Identification of gene clusters differentially expressed during the cellular injury responses (CIR) to cisplatin FREE
A Johnsson, P Byrne, R de Bruin, D Weiner, J Wong and G Los
Br J Cancer 85: 1206-1210; doi:10.1054/bjoc.2001.2080
Regular Articles
Profile of differentially expressed genes mediated by the type III epidermal growth factor receptor mutation expressed in a small-cell lung cancer cell line FREE
M W Pedersen, T Thykjær, T F Ørntoft, L Damstrup and H S Poulsen
Br J Cancer 85: 1211-1218; doi:10.1054/bjoc.2001.2053
Nucleolar damage correlates with neurotoxicity induced by different platinum drugs FREE
M J McKeage, T Hsu, D Screnci, G Haddad and B C Baguley
Br J Cancer 85: 1219-1225; doi:10.1054/bjoc.2001.2024
Analysis of the TSC1and TSC2genes in sporadic renal cell carcinomas FREE
L Parry, J H Maynard, A Patel, S C Clifford, C Morrissey, E R Maher, J P Cheadle and J R Sampson
Br J Cancer 85: 1226-1230; doi:10.1054/bjoc.2001.2072
Calendar
The published online date indicates the date that the issue is published online and is the first official publication date of the issue. Each print issue of BJC is published one week after it has been published online.
